| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -6,727,591 | -4,535,441 |
| Net increase in cash and cash equivalents | 4,292,244 | 761,874 |
| Cash and cash equivalents at beginning of period | 52,233,907 | - |
| Cash and cash equivalents at end of period | 56,526,151 | - |
IRADIMED CORP (IRMD)
IRADIMED CORP (IRMD)